We conducted a genome-wide association meta-analysis of 4,604 endometriosis cases and 9,393 controls of Japanese 1 and European 2 ancestry. We show that rs12700667 on chromosome 7p15.2, previously found to associate with disease in Europeans, replicates in Japanese (P = 3.6 × 10 −3 ), and we confirm association of rs7521902 at 1p36.12 near WNT4. In addition, we establish an association of rs13394619 in GREB1 at 2p25.1 with endometriosis and identify a newly associated locus at 12q22 near VEZT (rs10859871). Excluding cases of European ancestry of minimal or unknown severity, we identified additional previously unknown loci at 2p14 (rs4141819), 6p22.3 (rs7739264) and 9p21.3 (rs1537377). All seven SNP effects were replicated in an independent cohort and associated at P <5 × 10 −8 in a combined analysis. Finally, we found a significant overlap in polygenic risk for endometriosis between the genome-wide association cohorts of European and Japanese descent (P = 8.8 × 10 −11 ), indicating that many weakly associated SNPs represent true endometriosis risk loci and that risk prediction and future targeted disease therapy may be transferred across these populations.
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VOLUME 44 | NUMBER 12 | DECEMBER 2012 Nature GeNetics l e t t e r s individuals from the Hunter Community Study (HCS) 7 . After stringent quality control, the combined QIMR-HCS GWAS cohort consisted of 2,262 endometriosis cases and 2,924 controls, increasing the number of controls by 1,054 and the Australian effective sample size by 24%. We also performed more stringent quality control, incorporating the OX data set, resulting in a revised OX GWAS cohort of 919 endometriosis cases and 5,151 controls. All cases in the QIMR-HCS and OX studies have surgically confirmed endometriosis and disease stage from surgical records using the revised American Fertility Society (rAFS) classification system 8 ; subjects are grouped into stage A (stage 1 or 2 disease or some ovarian disease with a few adhesions; n = 1,680, 52.8%), stage B (stage 3 or 4 disease; n = 1,357, 42.7%) or unknown stage (n = 144, 4.5%). Details of the final GWAS and independent replication case-control cohorts are summarized in Table 1 , and a schematic of our study design is provided in Figure 1 .
Meta-analysis of all 4,604 endometriosis cases and 9,393 controls for the 407,632 SNPs that were represented in the QIMR-HCS, OX and BBJ GWAS data showed that the A allele of rs12700667 at the 7p15.2 locus in individuals of European ancestry (OR = 1.22, 95% CI = 1.13-1.31; P = 7.2 × 10 −8 ) also replicates in the Japanese GWAS data (OR = 1.22, 95% CI = 1.07-1.39; P = 3.6 × 10 −3 ), producing an overall OR of 1.22 (95% CI = 1.14-1.30) and P = 9.3 × 10 −10 in the GWAS meta-analysis; we also confirmed association with allele A of rs7521902 at the 1p36.12 WNT4 locus (OR = 1.18, 95% CI = 1.11-1.25; P = 4.6 × 10 −8 ) ( Table 2) .
The GWAS meta-analysis identified a previously unknown associated locus at 12q22 near the VEZT gene (allele C of rs10859871: OR = 1.18, 95% CI = 1.12-1.25; P = 5.5 × 10 −9 ). We also established association with allele G of rs13394619 in the GREB1 gene at 2p25.1 (OR = 1.12, 95% CI = 1.06-1.18; P = 2.1 × 10 −5 ), previously reported (OR = 1.35, 95% CI = 1.17-1.56; P = 3.8 × 10 −5 ) in a small independent Japanese GWAS of 696 cases and 825 controls 9 . The association for the G allele of rs13394619 approached conventional genome-wide significance (P ≤ 5 × 10 −8 ) in combined analysis of the QIMR-HCS, OX, BBJ, Adachi 500K and Adachi 6.0 npg l e t t e r s GWAS data (OR = 1.15, 95% CI = 1.09-1.20; P = 6.1 × 10 −8 ) ( Table 2 ). In addition to the 3 SNPs reaching genome-wide significance on chromosomes 1, 7 and 12 (rs7521902, rs12700667 and rs10859871, respectively), the Manhattan plot of all endometriosis genome-wide association meta-analysis results ( Supplementary Fig. 1 ) showed that 34 SNPs had suggestive evidence of association (P ≤1 × 10 −5 ).
Given the substantially greater genetic loading (or liability) of moderateto-severe (stage B) endometriosis (rAFS stage 3 or 4 disease) compared to minimal (stage A) endometriosis (rAFS stage 1 or 2 disease) 2 , a secondary analysis was performed for the SNPs with suggestive genome-wide association, with meta-analysis performed on the association results from QIMR-HCS and OX stage B cases versus controls with the BBJ association results (for which stage information not available).
After excluding endometriosis cases with minimal (rAFS stage 1 or 2) or unknown severity in the QIMR-HCS and OX cohorts, GWAS meta-analysis implicated new loci at 2p14 (allele C of rs4141819: OR = 1.22, 95% CI = 1.14-1.32; P = 6.5 × 10 −8 ), 6p22.3 (allele T of rs7739264: OR = 1.21, 95% CI = 1.13-1.30; P = 5.8 × 10 −8 ) and 9p21.3 (allele C of rs1537377: OR = 1.22, 95% CI = 1.14-1.30; P = 1.0 × 10 −8 ) ( Table 2 , Supplementary Fig. 2, Supplementary Tables 1 and 2 and Supplementary Note).
Annotated plots showing evidence for association in the combined QIMR-HCS, OX and BBJ GWAS data of genotyped SNPs across the seven implicated loci from the analysis of all cases and stage B cases only are provided in Supplementary Figures 3-9 . Imputation using the 1000 Genomes Project reference panel resulted in more significant P values and helped resolve the associated region at the 1p36.12 (rs56318008: P all = 1.3 × 10 −10 ), 2p25.1 (rs77294520: P stage B = 8.6 × 10 −8 ), 2p14 (rs2861694: P stage B = 7.9 × 10 −9 ), 6p22.3 (rs6901079: P all = 1.9 × 10 −8 ), 9p21.3 (rs7041895: P stage B = 5.1 × 10 −10 ) and 12q22 (rs11107968: P all = 3.9 × 10 −9 ) loci ( Fig. 2 and Supplementary Figs. 10-16 ). Of particular note, the imputed SNPs at 1p36.12 with the most significant association, rs56318008 and rs3820282 (P all = 1.6 × 10 −10 ), are located 22 bp 5′ to WNT4 and within the gene, respectively.
Notably, the most associated genotyped SNP at 9p21.3 (rs1537377) is 55 kb centromeric to the SNP associated with genome-wide significance that was reported in the original BBJ GWAS 1 (rs10965235) located in the CDKN2B-AS1 gene and 49 kb 3′ to the transcriptional end site of CDKN2B-AS1. The rs10965235 SNP is monomorphic in populations of European ancestry, and we investigated the independence of the associations at rs10965235 and rs1537377 in the BBJ GWAS data. First, in the BBJ GWAS data, alleles of rs10965235 and rs1537377 are very weakly correlated, with linkage disequilibrium (LD) metrics of r 2 = 0.028 and D' = 0.461. Second, the allelic association P values for rs10965235 and rs1537377 are 1.6 × 10 −4 and 1.8 × 10 −2 , respectively. After conditioning on rs10965235, weak residual association remained at rs1537377 (P = 9.0 × 10 −2 ). Consequently, the data suggest that there may be two independent genetic risk factors near the CDKN2B-AS1 locus at 9p21.3. CDKN2B-AS1 encodes a long non-coding RNA adjacent to and transcribed from the opposite strand of CDKN2B (p15), CDKN2A (p16) and ARF (p14). Loss of heterozygosity for CDKN2A and hypermethylation of the CDKN2A promoter have been reported in endometriosis 10, 11 .
To further validate the seven SNPs implicated by the meta-analysis, we carried out a replication study using a cohort of 1,044 cases and 4,017 controls obtained from BioBank Japan independent of the BBJ GWAS cohort. As shown in the forest plots of risk allele effects estimated using all cases versus controls (Fig. 3) , the effects (ORs) were in the same direction for all seven implicated SNPs across the GWAS and replication cohorts. With the exception of rs12700667, which was previously replicated (P = 1.2 × 10 −3 ) in 2,392 cases and 2,271 controls from the United States 2 , and rs4141819 (with marginal P = 5.1 × 10 −2 ), all SNPs were replicated with nominal significance at P < 0.05 ( Table 2) . All seven SNPs surpassed the conventional genome-wide significance threshold of P ≤ 5 × 10 −8 after combined analysis of the GWAS and replication cases and controls ( Table 2) . A conservative adjustment of the total P values for rs4141819 (P all = 8.5 × 10 −8 ; P stage B = 4.1 × 10 −8 ) for performing two independent GWAS (all and stage B endometriosis cases versus controls) would give P > 5 × 10 −8 (P all adjusted = 1.7 × 10 −7 ; P stage B adjusted = 8.2 × 10 −8 ). However, the accurately imputed (R 2 > 0.95) SNP rs2861694 (P stage B = 7.9 × 10 −9 ), in strong LD with rs4141819 (r 2 = 0.981, D' = 1.0, and r 2 = 0.867, D' = 1.0, in the 379 European and 286 Asian 1000 Genomes Project reference samples, respectively), would retain genome-wide significance (P stage B adjusted = 1.6 × 10 −8 ).
The quantile-quantile plots for the QIMR-HCS, OX and BBJ GWAS data (Supplementary Fig. 17a-c) reflect our stringent quality control, whereas the GWAS meta-analysis quantile-quantile plot (Supplementary Fig. 17d) shows a significant preponderance of SNPs with small P values of <1 × 10 −3 , suggesting that many of these nominally significant SNPs are likely to represent true signals 12 .
To further examine the shared genetic risk across our populations of European and Japanese ancestry, we performed polygenic npg l e t t e r s prediction analysis 13 to evaluate whether the aggregate effects of many variants of small effect in the BBJ GWAS cohort could predict affected status in the GWAS cohorts of European descent. The BBJ-derived risk scores significantly predicted affected status in the QIMR-HCS (R 2 = 0.0064; P = 6.9 × 10 −7 ), OX (R 2 = 0.0057; P = 9.6 × 10 −6 ) and combined QIMR-HCS and OX all-endometriosis case-control sets (R 2 = 0.0054; P = 8.8 × 10 −11 ). For the individual and combined QIMR-HCS and OX case-control sets, the variance explained peaked in the SNP sets with BBJ GWAS P of <0.1, using all genome-wide association meta-analysis SNPs (Fig. 4a) and after excluding all SNPs within 2,500 kb of the seven implicated SNPs listed in Table 1 (Fig. 4b) . Analogously, performing the prediction in reverse, the risk scores from the combined QIMR-HCS and OX sample significantly predicted affected status in the BBJ case-control set (R 2 = 0.0106; P = 3.3 × 10 −6 ) ( Supplementary  Fig. 18 and Supplementary Note) .
A gene-based genome-wide association analysis using the VEGAS (versatile gene-based association study) program 14 , which accounts for gene size and LD between SNPs, identified 1,184 genes with combined P of ≤0.05 and determined that the top 3 ranked genes associated with endometriosis were WNT4 at 1p36.12 (P = 5.0 × 10 −9 ), VEZT at 12q22 (P = 5.7 × 10 −7 ) and GREB1 at 2p25.1 (P = 2.5 × 10 −5 ) ( Supplementary Table 3 ). In addition to identifying SNPs that reached genome-wide significance near the top three genes, we found that the WNT4 and VEZT genes easily surpassed our conservative gene-based threshold for significant association of P ≤2.85 × 10 −6 (calculated as P = 0.05/17,538 independent genes). WNT4 encodes wingless-type MMTV integration site family, member 4, and is important for the development of the female reproductive tract 15 and steroidogenesis 16 . VEZT encodes vezatin, an adherens junctions transmembrane protein that is downregulated in gastric cancer 17 . GREB1 encodes growth regulation by estrogen in breast cancer 1, an early response gene in the estrogen regulation pathway that is involved in hormone-dependent breast cancer cell growth 18 . For the four remaining implicated regions at 2p14, 6p22.3, 7p15.2 and 9p21.3, no genes showed significant association (P ≤ 1.3 × 10 −3 ) after adjusting VEGAS results for testing 37 genes across all 7 regions (Table 2, Supplementary Figs. 3-9 and Supplementary Table 4 ).
In conclusion, given their high gene-based ranking, proximity to genome-wide significant SNPs, known pathophysiology and reported gene expression ( Supplementary Fig. 19 and Supplementary Note) , the WNT4, VEZT and GREB1 genes are strong candidates for further studies aimed at understanding the molecular pathogenesis of endometriosis. Our results also suggest that a considerable number of SNPs that were nominally implicated (for example, at P < 0.1) in the GWAS cohorts of individuals of European and Japanese descent represent true endometriosis risk loci. Moreover, the significant overlap in common polygenic risk for endometriosis indicates that genetic risk prediction and future targeted disease therapy may be transferred across these populations. Figure 3 Forest plots of risk allele effects for the seven SNPs reaching genome-wide significance in the individual and total endometriosis case-control cohorts.
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Figure 4
Allele-specific score prediction for endometriosis, using the BBJ population as the discovery data set and the combined QIMR-HCS and OX population as the target data set. (a,b) The variance explained in the target data set on the basis of allele-specific scores derived in the discovery data set for 12 significance thresholds. The y axis indicates Nagelkerke's pseudo R 2 , representing the proportion of variance explained. The number above each bar is the P value for the target data set prediction analysis (R 2 significance). Prediction was performed using all GWAS meta-analysis SNPs (a) and after excluding all SNPs within 2,500 kb of the seven implicated SNPs listed in table 1 (b). The results were not driven by a few highly associated regions, indicating that a substantial number of common variants underlie endometriosis risk. npg l e t t e r s METAL, http://genome.sph.umich.edu/wiki/METAL_Program; METASOFT, http://genetics.cs.ucla.edu/meta/index.html; minimac, http://genome.sph.umich.edu/wiki/Minimac; 1000 Genomes Imputation Cookbook, http://genome.sph.umich.edu/wiki/Minimac:_ 1000_Genomes_Imputation_Cookbook; 1000 Genomes Project, http:// www.1000genomes.org/; PLINK, http://pngu.mgh.harvard.edu/~purcell/ plink/; SNPSpD, http://genepi.qimr.edu.au/general/daleN/SNPSpD/; Wellcome Trust Case Control Consortium, http://www.wtccc.org.uk/.
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